e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Inflammation and remodelling in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of estrogen receptors and estrogen metabolism genes in lungs of COPD patients
Juanita H.J. Vernooy (Maastricht, Netherlands), Gonda Konings, Niki Reynaert, Andrea Romano, Ken Bracke, Guy Brusselle, Emiel Wouters, Juanita Vernooy
Source:
International Congress 2015 – Inflammation and remodelling in lung disease
Session:
Inflammation and remodelling in lung disease
Session type:
Thematic Poster Session
Number:
3921
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Juanita H.J. Vernooy (Maastricht, Netherlands), Gonda Konings, Niki Reynaert, Andrea Romano, Ken Bracke, Guy Brusselle, Emiel Wouters, Juanita Vernooy. Expression of estrogen receptors and estrogen metabolism genes in lungs of COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3921
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Plasma levels of TIPM-2 in patients with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Leptin receptor polymorphisms and lung function decline in COPD
Source: Eur Respir J 2009; 34: 103-110
Year: 2009
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome
Source: International Congress 2015 – COPD: notable points
Year: 2015
MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
The effects of endogenous and exogenous vitamin D on the rate of mature elastin degradation in COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Bronchial epithelial gene expression of NOX isoforms are related to important clinical characteristics in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Metabolomics profiling identifies female-selective upregulation of oxidative stress in individuals with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Distinct localization of estrogen receptors in lungs of severe COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Cigarette smoke-induced lung inflammation is skewed in estrogen receptor-alpha deficient mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept